Add BrightSurf on Google Email

Brain biomarkers of Alzheimer's disease can be detected as early as middle age

A Finnish population study reveals that middle-aged individuals can have high levels of blood-based biomarkers associated with Alzheimer's disease. The study found a link between kidney disease and higher biomarker levels in middle age, as well as an association between the APOE ε4 gene and older age biomarker concentrations. Further r...

SourceUniversity of Turku·JournalThe Lancet Healthy Longevity·DateJul 14, 2025

Spatial and single-cell omics propel precision biomarker discovery in tumor immunotherapy, review finds

A new review leverages cutting-edge spatial transcriptomics and single-cell omics to identify robust predictive biomarkers for tumor immunotherapy. Representative case studies highlight the potential of spatially resolved markers to guide immunotherapy decisions and predict irAE risk.

SourceShanghai Jiao Tong University Journal Center·JournalLabMed Discovery·TypeNews article·DateJul 10, 2025

Most patients with advanced melanoma who received pre-surgical immunotherapy remain alive and disease free four years later

A Phase II study found that 87% of patients with stage III melanoma remained alive and disease-free four years after treatment with nivolumab and relatlimab. Researchers identified unique biomarkers associated with better outcomes, including high TIGIT levels and low B7-H3 levels.

SourceUniversity of Texas M. D. Anderson Cancer Center·JournalJournal of Clinical Oncology·DateJul 10, 2025

Manipulation of light at the nanoscale helps advance biosensing

Researchers at the University of Illinois developed cryosoret nanoassemblies that enhance fluorescence signals, reducing detection limits for biomarkers. The new platform offers dual-mode interaction between electric and magnetic components of light, promising highly sensitive and tunable biosensing systems.

Pusan National University scientists uncover gene mutation tied to poor outcomes in transplant patients

Scientists from Pusan National University discovered a genetic biomarker, FCGBP, that is strongly linked to bronchiolitis obliterans syndrome and poor outcomes following lung transplantation. The finding may help identify high-risk patients and devise timely immunosuppressive treatments.

SourcePusan National University·JournalThe Journal of Heart and Lung Transplantation·TypeExperimental study·DateJun 30, 2025

Newborns have elevated levels of a biomarker for Alzheimer's

A study by researchers at the University of Gothenburg found that newborn babies and patients with Alzheimer's disease share elevated levels of phosphorylated tau, specifically p-tau217. In newborns, this protein reflects a healthy mechanism for brain development, while in Alzheimer's patients, it indicates disease progression.

SourceUniversity of Gothenburg·JournalBrain Communications·TypeObservational study·DateJun 24, 2025

ImmunoCheckDB: A comprehensive web platform integrating meta-analysis and multiomic profiling to advance cancer immunotherapy biomarker discovery

The study presents ImmunoCheckDB, a web platform that bridges a critical gap in existing resources by enabling pan-cancer exploration of immune checkpoint inhibitor therapies through combined meta-analytical and multiomic approaches. It curates 173 studies involving 93,234 individuals across 18 cancer types and 30 ICI regimens.

NUS Medicine researchers develop a better and more accurate biological ageing clock

Researchers developed an improved biological ageing clock, LinAge2, that offers doctors a practical way to assess how quickly a person is ageing and what can be done to slow it down. The new algorithm-powered tool outperforms other clinical models in predicting long-term mortality and health outcomes.

SourceNational University of Singapore, Yong Loo Lin School of Medicine·Journalnpj Aging·TypeComputational simulation/modeling·DateJun 8, 2025

MET mutation and cancer immunity

A recent study found that MET mutations are associated with enhanced tumor immunogenicity, increased immune cell infiltration, and improved response rates to immune checkpoint blockade. Certain single base substitutions identified as robust predictive biomarkers for survival in pan-cancer immunotherapy.

SourceCompuscript Ltd·JournalGenes & Diseases·DateJun 5, 2025

Annual Alzheimer's clinical trials pipeline report shows increased reason for optimism

The annual Alzheimer's disease drug development pipeline report, led by Dr. Jeffrey Cummings, highlights an increase in active clinical trials and promising drugs, offering reason for optimism. The report assesses 138 drugs currently being studied and notes the growing importance of biomarkers in clinical trials.

SourceUniversity of Nevada, Las Vegas·JournalAlzheimer s & Dementia Translational Research & Clinical Interventions·TypeSystematic review·DateJun 3, 2025

Tiny microlaser sensors offer supercharged biosensing

Researchers have developed a 3D micro-printed sensor that uses whispering-gallery-mode microlasers to detect biomarkers with attogram per milliliter sensitivity. The sensors' unique Limacon-shaped design improves efficiency and enables on-chip integration, making them suitable for high-performance lab-on-a-chip devices.

SourceOptica·JournalOptics Letters·DateMay 19, 2025

USC researchers develop low-cost blood test for early Alzheimer’s detection

Researchers from USC Keck School of Medicine have developed a low-cost blood test that detects five biomarkers of Alzheimer's disease, including amyloid and tau proteins. The test uses xMAP technology and has the potential to catch the disease in its earliest stages, when treatment might be able to prevent or delay cognitive decline.

SourceKeck School of Medicine of USC·JournalJournal of Alzheimer’s Disease·TypeExperimental study·DateMay 15, 2025

Novel blood-based biomarker analysis provides insights to improve therapy decisions and treatment outcomes for patients with metastatic disease

Researchers identified platelets, C-reactive protein, and chromogranin A as markers that can predict the failure of hormone-sensitive prostate cancer treatment. The study also found that miR-375 expression and lymphocyte-to-monocyte ratio are negative predictors for therapy failure in castration-resistant prostate cancer patients.

SourceElsevier·JournalJournal of Molecular Diagnostics·TypeObservational study·DateMay 12, 2025

Krebs von den Lungen-6 as a biomarker for distinguishing between interstitial lung disease and interstitial lung abnormalities based on computed tomography findings

Serum Krebs von den Lungen-6 (KL-6) levels are significantly elevated in patients with interstitial lung disease (ILD), suggesting its potential as a diagnostic biomarker. The study also highlights the relationship between KL-6 levels and pulmonary function, specifically forced vital capacity.

SourceNational Center for Respiratory Medicine·JournalJournal of Thoracic Disease·TypeObservational study·DateMay 9, 2025

Periostin, a valuable serum biomarker in the diagnosis of idiopathic pulmonary fibrosis and prediction of acute exacerbations

This study reveals periostin as a superior serum biomarker for diagnosing idiopathic pulmonary fibrosis, with high sensitivity and specificity compared to traditional markers. Periostin levels also correlate with disease severity and predict acute exacerbations in IPF patients.

SourceNational Center for Respiratory Medicine·JournalJournal of Thoracic Disease·TypeObservational study·DateMay 8, 2025

Breakthrough provides new hope for patients with knee osteoarthritis

Scientists at Henry Ford Health + Michigan State University Health Sciences have identified a circulating microRNA called miR-126-3p as a mechanistic biomarker of knee osteoarthritis. This discovery may lead to the development of blood tests for early detection and therapeutics for slowing or stopping disease progression.

SourceHenry Ford Health·JournalNature Communications·TypeRandomized controlled/clinical trial·DateMay 1, 2025

Detecting Parkinson's disease with a simple retinal exam

Researchers from Université Laval discovered a non-invasive retinal exam can detect Parkinson's disease biomarkers, offering early diagnosis and potential intervention. The study found distinct retinal responses to light stimuli in people with Parkinson's compared to healthy individuals.

SourceUniversité Laval·JournalNeurobiology of Disease·TypeExperimental study·DateMay 1, 2025

Molecular tests provide more convenient, personalized monitoring of heart transplant recipients

New molecular testing methods are transforming post-transplant care by detecting potential heart injury or rejection earlier than traditional biopsies. This enables physicians to reduce immunosuppressive medicine dosage in low-risk patients, potentially improving patient outcomes beyond the first year post-heart transplant.

Urine test could reveal prostate cancer

Researchers at Karolinska Institutet have identified new biomarkers in urine that can indicate the presence and severity of prostate cancer with high precision. The findings surpass current blood biomarker PSA in terms of diagnostic accuracy.

SourceKarolinska Institutet·JournalCancer Research·TypeComputational simulation/modeling·DateApr 28, 2025

The potential oncogenic role of serum-derived hsa_circ_101555 as a non-invasive diagnostic/prognostic marker in patients with hepatocellular carcinoma

The study found that serum-derived hsa_circ_101555 showed excellent diagnostic accuracy in differentiating HCC patients from healthy controls. It also demonstrated a prognostic role in predicting tumor progression and response to therapy, with significant correlations with markers of liver inflammation and tumor features.

SourceXia & He Publishing Inc.·JournalGene Expression·DateApr 24, 2025

Singapore scientists unveil one of world’s largest long-read RNA sequencing datasets to advance disease research

A team of Singaporean scientists has released a comprehensive long-read RNA sequencing dataset, SG-NEx, to accelerate biomarker discovery and precision medicine. The dataset offers deeper biological insights into RNA complexity, enabling researchers to detect clinically relevant biomarkers and develop better treatments.